The Effect of Total Parenteral Nutrition on Hepatic Drug Oxidation
- 1 November 1987
- journal article
- research article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 11 (6) , 540-543
- https://doi.org/10.1177/0148607187011006540
Abstract
Hepatic dysfunction is a frequent complication of total parenteral nutrition (TPN), indicated by derangement of standard liver function tests. However, such changes are variable and nonspecific, and represent hepatic injury rather than changes in hepatic function. Antipyrine (Phenazone) clearance is a sensitive indicator of hepatic microsomal enzyme activity and provides a more specific indication of hepatic function. This was used to investigate the effect of different TPN regimens. Patients receiving a postoperative 2000 kcal TPN regimen providing all nonprotein calories as dextrose (n = 16) showed a 34% reduction of mean antipyrine clearance after 7 days of TPN compared to controls (n = 13, p < 0.05). This effect was seen also in patients receiving a 1600 kcal dextrose-based regimen (n = 8). In patients receiving a 2000 kcal TPN regimen in which 500 kcal were provided as lipid (n = 10), mean antipyrine clearance was not significantly different from that of the control group. This study indicates the sensitivity of hepatic microsomal oxidative function, an important route of drug metabolism, to different TPN regimens. (Journal of Parenteral and Enteral Nutrition 11:540-543, 1987)This publication has 19 references indexed in Scilit:
- Pathogenesis of hepatic steatosis in the parenterally fed rat.Journal of Clinical Investigation, 1984
- New Approaches to Assessment of Drug Disposition in the Surgical PatientAnesthesiology, 1984
- The grading of sepsisBritish Journal of Surgery, 1983
- Assessment of the drug metabolism capacity of the liver.British Journal of Clinical Pharmacology, 1982
- The antipyrine test in clinical pharmacology: Conceptions and misconceptionsClinical Pharmacology & Therapeutics, 1979
- Measurement of urinary 6-?-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicinEuropean Journal of Clinical Pharmacology, 1979
- Hepatic Dysfunction During HyperalimentationArchives of Surgery, 1978
- Assessment of antipyrine kinetics by measurement in saliva.British Journal of Clinical Pharmacology, 1976
- Rapid gas-liquid chromatographic estimation of antipyrine in plasmaJournal of Pharmacy and Pharmacology, 1973
- Dietary fatty acid-induced alterations of hepatic microsomal drug metabolismBiochemical Pharmacology, 1972